Clinical Trial Update: The AFteR Registry - Follow-up Study to Monitor the Efficacy and Safety of the Occlutech AFR in Heart Failure Patients

View source ↗

Summary

The AFteR Registry is a follow-up study to monitor the efficacy and safety of the Occlutech AFR device in heart failure patients and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Occlutech AFR

Snippet

Sponsor: Occlutech International AB | Conditions: Heart Failure | Status: RECRUITING